Skip to main content

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Aims and Scope

Cell Communication and Signaling (CCS) is an open access journal that encompasses all basic and translational aspects of cellular communications and signaling pathways in normal and pathological conditions.

Beginning in January of 2019, CCS is pleased to announce their affiliation with the International Cell Death Society

The journal encourages submissions in all aspects of cell death, that include apoptotic and non-apoptotic mechanisms of cell death, cell death in model systems, autophagy, clearance of dying cells, as well as the immunological and pathological consequences of dying cells in the tissue microenvironment. 

Read more


News & Updates

13th Annual ÖGMBT Annual Meeting
The 2021 Meeting of the Austrian Association of Molecular Life Sciences and Biotechnology will be held virtually 20th September to 14 October, 2021. For more information and updates, please visit the Meeting Website. 

New Thematic Series open for submissions
Guest Editors Nicole Meisner-Kober and Silja Wessler are welcoming submissions to their new series on Extracellular Vesicles in Infectious Disease. Learn more about the series here

Call for papers

Extracellular vesicles in infectious disease
Edited by Dr. Nicole-Meisner Kober and Dr Silja Wessler
Submission Deadline: March 1, 2022
Kinases, adaptor proteins, and actin cytoskeleton rearrangements in EMT and cancer

Edited by Dr. Leszek Kotula and Dr. Patrycja Dubielecka-Sczerba
Submission Deadline: December 31, 2021

The roles of intrinsically disordered proteins and regions (IDPs and IDRs) in cell communication and cell signaling
Edited by Dr. Sarah Bondos, Dr. A. Keith Dunker and Dr. Vladimir Uversky
Submission Deadline: July 1, 2021

Submit your manuscript here.

Featured Articles

New Content Item
Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage

In a recent review article, Ternet & Kiel highlight the role of KRAS in the intestinal epithelium and in colorectal cancer for processes such as cell proliferation, cell junction formation and remodelling, hypoxia, the immune system, inflammation, and metabolism. As KRAS is considered undruggable, they discuss the suitability of targeting pathways downstream of KRAS as well as alterations of cell extrinsic/ microenvironmental factors as possible targets for modulating signaling pathways in colorectal cancer.

New Content Item
L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness

By combining biological methods with computational modeling, this study has investigated the signaling network leading to Ser5 phosphorylation of the actin-bundling protein L-plastin. Machado et al.'s approach has revealed that L-plastin is a target of both the ERK/MAPK and the PI3K signaling pathways. Downstream of PI3K, SGK3 was identified as a novel kinase able to phosphorylate L-plastin on Ser5. Furthermore, our results have illustrated that Ser5 phosphorylation promotes the recruitment of L-plastin to invadopodia, increases extracellular matrix degradation and enhances invasion of breast cancer cells. The authors propose L-plastin Ser5 phosphorylation as a therapeutic target to reduce breast cancer cell invasiveness.

Video Bytes are here

At Cell Communication and Signaling, we are passionate about the dissemination of research.

We are pleased to announce that as of the 12th August 2019, all authors whose papers are accepted will receive a Video Byte.

Created by our partners, Research Square, a Video Byte is a 1-2 minute video summary of a paper that will be incorporated into the abstract of the paper and published on the journal website. Authors will also receive a shareable version of their Video Byte.

Editor's profile

New Content Item (1)Raymond Birge, Editor-in-Chief

Raymond Birge, PhD., is a Professor at Rutgers, The State University of New Jersey and member of the New Jersey Medical School Cancer Center. Dr. Birge joined UMDNJ-New Jersey Medical School in 2000 and currently holds a position of Professor and Vice Chair for Research in the Department of Microbiology, Biochemistry and Molecular Biology. Dr. Birge also has joint appointments at the New Jersey Medical School Cancer Center (Newark) and the Cancer Institute of New Jersey (New Brunswick). 

Annual Journal Metrics